Shan Peng
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening.
Journal: Annals of medicine
Published: December 17, 2025
Preclinical activity of SHR-A1921, a novel antibody-drug conjugate targeting trophoblast cell-surface antigen2 (Trop-2) in prostate cancer.
Journal: Frontiers in pharmacology
Published: September 26, 2025
Neoadjuvant pamiparib plus abiraterone and androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: an open-label, single-arm, phase 2 study.
Journal: Prostate cancer and prostatic diseases
Published: August 09, 2025
HDAC2 as a therapeutic target in bladder cancer: insights into the altered epigenetic regulation and lysine lactylation.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 03, 2025
Can the contralateral systematic prostate biopsy be omitted in men with unilateral index lesion on MRI? A single-center retrospective study.
Journal: World journal of urology
Published: March 27, 2025
The Dual Threat Combined Pulmonary Fibrosis and Emphysema (CPFE): Two Cases.
Journal: International journal of chronic obstructive pulmonary disease
Published: March 07, 2025
The expression of prostate-specific membrane antigen in intraductal carcinoma of the prostate.
Journal: Scientific reports
Published: February 12, 2025
Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND.
Journal: Nature communications
Published: December 16, 2024
Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysis.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 28, 2024
Last Updated: 09/26/2026